abrdn Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$262M Buy
8,225,346
+48,263
+0.6% +$1.52M 0.89% 37
2017
Q1
$265M Sell
8,177,083
-552,434
-6% -$17.4M 0.88% 39
2016
Q4
$269M Sell
8,729,517
-1,468,233
-14% -$44.8M 0.94% 36
2016
Q3
$328M Sell
10,197,750
-439,157
-4% -$14.7M 1.35% 20
2016
Q2
$355M Sell
10,636,907
-7,355
-0.1% -$235K 1.61% 18
2016
Q1
$299M Sell
10,644,262
-541,796
-5% -$15.5M 1.36% 24
2015
Q4
$343M Buy
11,186,058
+9,557,947
+587% +$301M 1.45% 25
2015
Q3
$48.5M Sell
1,628,111
-1,145,820
-41% -$36.7M 0.21% 103
2015
Q2
$88.2M Sell
2,773,931
-400,913
-13% -$13.1M 0.37% 85
2015
Q1
$105M Sell
3,174,844
-492,025
-13% -$15.6M 0.43% 78
2014
Q4
$108M Sell
3,666,869
-18,406
-0.5% -$528K 0.43% 70
2014
Q3
$103M Sell
3,685,275
-2,545,890
-41% -$71.5M 0.39% 76
2014
Q2
$175M Sell
6,231,165
-1,274,597
-17% -$36.3M 0.78% 46
2014
Q1
$229M Sell
7,505,762
-3,792,262
-34% -$113M 1.09% 35
2013
Q4
$328M Sell
11,298,024
-187,237
-2% -$5.45M 1.74% 8
2013
Q3
$313M Sell
11,485,261
-1,639,966
-12% -$44.6M 1.81% 6
2013
Q2
$349M Buy
+13,125,227
New +$363M 2.21% 3

Other funds holding PFE

abrdn Investment Management's PFE Position: Q2 2017 in Review

abrdn Investment Management increased its Pfizer (PFE) stake by 0.59% in Q2 2017, buying an estimated $1.52M and bringing the position to 8,225,346 shares worth $262M. The position accounts for 0.89% of the portfolio, ranked #37.

abrdn Investment Management first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $355M in Q2 2016. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • abrdn Investment Management held 8,225,346 shares of Pfizer worth $262M as of Q2 2017.
  • abrdn Investment Management bought 48,263 Pfizer shares in Q2 2017, an estimated $1.52M.
  • Pfizer made up 0.89% of abrdn Investment Management's portfolio in Q2 2017, its #37 holding.
  • abrdn Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
  • abrdn Investment Management's Pfizer position peaked at $355M in Q2 2016.
  • 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.